Ketorolac may control more than pain.
Life-threatening acute respiratory distress syndrome (ARDS) complicates the recovery of patients with burn and inhalation injury. The study by Enkhbaatar and co-workers in this issue of Clinical Science suggests that reducing the early and robust inflammatory cascade may provide patients with protection from developing cardiopulmonary compromise seen early after burn and inhalation injury.
Isik
Frank
F
University of Washington Medical Center, 1959 NE Pacific Street, Box 356410, Seattle WA 98195, USA.
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology*; D002056:Burns / Q000150:complications* / Q000276:immunology; D006801:Humans; D020910:Ketorolac / Q000494:pharmacology*; D010146:Pain / Q000188:drug therapy*; D012128:Respiratory Distress Syndrome / Q000276:immunology / Q000517:prevention & control*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D020910:Ketorolac